Paul Driessen

The $14-million study claimed that these interventions resulted in an unprecedented “63% reduction in the number of people with [malaria], without using DDT or any other type of pesticide.” However, as analyses by malaria and insecticide experts Richard Tren and Dr. Donald Roberts clearly demonstrate (see Research and Reports in Tropical Medicine and AEI Outlooks), the study, conclusions and policy recommendations are not merely wrong. They are deliberately misleading and fraudulent.

GEF did its 2003-2008 study in Mexico and seven Central American countries – all of which had largely ceased using DDT and other pesticides years before the GEF project. Instead of chemical sprays, these countries now employ huge numbers of chloroquine and primaquine (CQ and PQ) pills to prevent and treat malaria: 2,566 pills per diagnosed case in Mexico; 22,802 pills (!) in El Salvador; 50 to 1,319 pills per case in the other countries, according to 2004 health records.

It was these powerful drugs, not the “environment-friendly” GEF interventions, that slashed malaria rates. Indeed, they had begun to do so before GEF even arrived. This terribly inconvenient reality was further underscored by the fact that malaria rates were the same in “study” areas and “control” areas, where GEF did nothing – and that the number of malaria cases increased when the number of pills per case decreased. In other words, GEF could have gotten its same results using one bed net or one larvae-eating fish.

GEF’s fraudulent claims were then compounded by its insistence that the results and conclusions are relevant to other malaria-endemic regions. They are not. Malaria parasites in Latin American countries are

Plasmodium vivax; in Africa and Southeast Asia, they are the far more virulent P. falciparum.

CQ and PQ are effective in preventing and treating vivax; they rarely prevent or cure falciparum malaria. Moreover, the eight Latin American countries have 140 million people. Sub-Saharan Africa has 800 million and a woeful medical and transportation infrastructure; Southeast Asia has 600 million people. Both have infinitely more malaria. Getting adequate medicines that work (far more expensive Artemisia-based ACT drugs) to 1.4 billion people would be a budgetary, logistical and medical impossibility.

But apparently none of these facts occurred to the bureaucrats who did this study. That’s hardly surprising, since the project was designed and directed, not by disease control experts, but by the UNEP and radical environmental groups – which also spent millions distributing and promoting the study and other anti-DDT propaganda all over the world, ensuring that it received substantial media attention.

The anti-pesticide fanatics know this “study” is fraudulent. They just have a very high tolerance for how many malaria cases, brain-damaged people and dead babies are deemed “acceptable” or “sustainable.” They just don’t care enough to bother learning the basic facts about malaria, CQ versus ACT, vivax versus falciparum. They need to get out of the malaria control policy business and let medical professionals do their jobs.

(To learn more facts about malaria, see Tren and Roberts’ book The Excellent Powder, Dr. Rutledge Taylor’s documentary film “3 Billion and Counting,” and the website for Africa Fighting Malaria.)

The final report claims its authors submitted manuscripts to prominent peer-reviewed medical journals. However, nothing was ever published. That suggests that they lied, and never submitted any manuscripts; or they did submit papers, but they were rejected as being shoddy, unscientific, unprofessional, or even on par with Andrew Wakefield’s fraudulent vaccine-and-autism work.

To cap it all off, the bogus GEF project appears to have been conducted using funds diverted from already insufficient malaria control budgets. The GEF, UNEP, Stockholm Convention Secretariat and radical environmental groups are using money intended for malaria control to launch anti-pesticide programs in countries plagued by malaria, and gain control over public health insecticides, policies and programs.

Overall, the GEF has spent over $800 million on efforts to eliminate DDT and other “persistent organic pollutants” (POPs). It budgeted nearly $150 million in 2007 alone on its campaign to ban DDT production and use – but spent a lousy $22 million researching alternatives to DDT for vector control.

Until an equally effective and long-lasting substitute for DDT is developed – one that repels, irritates and kills mosquitoes – this vital weapon needs to remain in the disease control arsenal.

The GEF, UNEP, POPs Secretariat and WHO need to withdraw the study; discipline the people who perpetrated this fraud; retract World Health Assembly Resolution 50.13, calling for malaria-infested countries to slash their use of public health insecticides; and issue a statement making it absolutely clear that this “study” was erroneous and deceptive, and should not be considered in setting malaria policies.

Donors to the GEF and radical groups should be exposed. For any activists to continue promoting this study or demand that malaria-endemic countries stop using DDT and insecticides, and adopt the bogus “eco-friendly” GEF “solutions,” is gross medical malpractice – and deliberate manslaughter.

Malaria can be controlled, and even eradicated in many areas. We simply need to use every available weapon – including DDT, pesticides, nets, window screens, drugs and other interventions – in an orderly, coordinated and systematic manner; and ensure that mosquito infestations, disease outbreaks, malaria control successes and problems are monitored and evaluated accurately and honestly.

If we do that – and end the anti-pesticide hysteria – we can get the job done.

Paul Driessen

Paul Driessen is senior policy adviser for the Committee For A Constructive Tomorrow (CFACT), which is sponsoring the All Pain No Gain petition against global-warming hype. He also is a senior policy adviser to the Congress of Racial Equality and author of Eco-Imperialism: Green Power - Black Death.

Be the first to read Paul Driessen's column. Sign up today and receive delivered each morning to your inbox.